Drugs / Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine
Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02919293 Comparator | Aug 2016 → Mar 2017 | meningococcal meningitis | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02919293 ↗ |
| Modality | Vaccine | “Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)” NCT02919293 ↗ |
| Route | Intramuscular | “0.5ml /dose, Intramuscular” NCT02919293 ↗ |